Please login to the form below

Not currently logged in
Email:
Password:

AcelRx

This page shows the latest AcelRx news and features for those working in and with pharma, biotech and healthcare.

Grunenthal and AcelRx’s Zalviso approved in EU

Grunenthal and AcelRx’s Zalviso approved in EU

Grunenthal and AcelRx’ s Zalviso approved in EU. Provides new treatment for post-operative pain. ... Howie Rosen, interim CEO of AcelRx, said: “ This is a significant event for AcelRx.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Pharma deals in September 2015 Pharma deals in September 2015

    PDL BioPharma is buying out the majority of the expected royalty stream from EU sales of AcelRX's phase III product, Zalviso for $65m. ... Royalty monetisation. 110. AcelRx Pharmaceuticals. PDL BioPharma. Zalviso sub-lingual formulation of sufentanil.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Raffi Asadorian joins AcelRx Pharmaceuticals Raffi Asadorian joins AcelRx Pharmaceuticals

    Speciality pharmaceutical company AcelRx Pharmaceuticals has appointed Raffi Asadorian as its new chief financial officer. ... Vince Angotti, chief executive officer at AcelRx, said: “I am thrilled to have Raffi join our team.

  • Dr Stephen Hoffman joins Bicycle Therapeutics Dr Stephen Hoffman joins Bicycle Therapeutics

    He is also a member of the board of directors of AcelRx Pharmaceuticals, Dicerna Pharmaceuticals and Genocea Biosciences.

  • Kala names Howard Rosen as chairman Kala names Howard Rosen as chairman

    Rosen has held several senior roles at major biotechs, including his current positions on the board of directors at AcelRX, Aldea, Entrega and PaxVax, where he is also chairman.

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics